Industry in dispute with DoE over biotechnology regulation

Biotechnology businesses have continued their campaign for a relaxation of the EC rules governing the production and deliberate release of genetically manipulated organisms (GMOs) before an inquiry in the House of Lords. The industry maintains that the technology poses risks no higher than those of any other. But the Department of the Environment (DoE) and environmentalists have told the inquiry that regulation should err on the side of caution while commercialisation of GMOs is still in its infancy.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here

Email: report@ends.co.uk

Call: 020 8267 8120

Register for
Free Trial

  • 14 day access to subscriber-only content

Register

Subscribe

Prices on request

  • Full access to endsreport.com for 12 months
  • Monthly print issues
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits